MassMutual Private Wealth & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MassMutual Private Wealth & Trust's XBI Position: Q1 2025 in Review
MassMutual Private Wealth & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 36 shares — an estimated $3.24K sold.
MassMutual Private Wealth & Trust first reported a position in XBI in Q1 2021 and held it in 12 quarters. The position peaked at $96K in Q2 2021. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.
- MassMutual Private Wealth & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
- MassMutual Private Wealth & Trust sold 36 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $3.24K.
- MassMutual Private Wealth & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and held it in 12 quarters.
- MassMutual Private Wealth & Trust's State Street SPDR S&P Biotech ETF position peaked at $96K in Q2 2021.
- 682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.
Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.